Explore more publications!

Press Releases

$EOSE: Eos Energy Enterprises, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
IPG Photonics Receives Order From Lockheed Martin for CROSSBOW™ High-Energy Laser Systems
Stent Recall: Boston Scientific Removes Certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems

Stent Recall: Boston Scientific Removes Certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems

Stent Recall: Boston Scientific Removes Certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems

Stent Recall: Boston Scientific Removes Certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems

Arionkoder Presents a Solution for the Trust Barrier in AI
Boston Beer Reports Fourth Quarter Financial Results
Boston Scientific’s Global Endoscopy Team Partners with United Planet for Humanitarian Expedition in Mérida, Mexico
SWEET HOME ALABAMA: American Rebel (NASDAQ: AREB) Signs Powerhouse Partnership for American Rebel Light Beer with Industry Titan Gulf Distributing, Securing Statewide Saturation for "America’s Patriotic Beer"
Nkarta to Participate in March Investor Conferences
ARKO Opens Its Second New to Industry Store in Less Than a Month — A Pride Location In Agawam, Massachusetts
Federal Judge Blocks Trump Administration’s Rapid Deportation Policy

Federal Judge Blocks Trump Administration’s Rapid Deportation Policy

X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
Boston Vitality Declares To Continue Leading In Men's Hormone Health Care
Keyport Recruits Seafood Industry Leader Craig Morris as President to Accelerate Growth
Assisting Massachusetts with Snow Removal

Assisting Massachusetts with Snow Removal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
Lakeland Industries, Inc. Sued For Securities Law Violations; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions